CP-664511

Chemical Name: 3-[3-[1(S)-[2-[3-Methoxy-4-[3-(2-methylphenyl)ureido]phenyl]acetamido]-3-methylbutyl]isoxazol-5-yl]propionic acid
CAS No. 379692-00-9, 253347-08-9 (racemate)
项目整合开发状态: Preclinical
项目研究机构: Pfizer (Originator)
合成路线:The isoxazolepropionate intermediate (IV) has been obtained as follows: The cyclization of N-(tert-butoxycarbonyl)-L-leucinal oxime (I) with 4-pentynoic acid methyl ester (II) by means of NaOCl and TEA in dichloromethane gives the protected isoxazole derivative (III),which is then treated with Cl in dioxane to afford the desired isoxazole intermediate (IV).

合成路线:The condensation of 5-chloro-2-nitroanisole (V) with diethyl malonate (VI) by means of NaH in hot DMF gives 2-(3-methoxy-4-nitrophenyl)malonic acid diethyl ester (VII),which is reduced with H2 over Pd/C in ethyl acetate,yielding the corresponding amino derivative (VIII).The condensation of (VIII) with 2-methylphenyl isocyanate (IX) by means of TEA in dichloromethane affords the expected urea (X),which is submitted to a decarboxylative hydrolysis with NaOH in refluxing tert-butanol to provide the phenylacetic acid (XI).The condensation of acetic acid (XI) with the amino group of the isoxazole intermediate (IV) by means of HOBt,DIEA and EDC in DMF gives the amide (XII),which is treated with NaOH in tert-butanol to afford the target propionic acid.